4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-22-006243
CHIEF EXECUTIVE OFFICER bought 15,000 shares at $2.27 ($34,050)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 2022-09-26 | Purchase | +15,000 | $2.27 | $34,050 | 5,421,873 | D |
| Open-market purchases · 15,000 sh · avg $2.27 · $34,050 | |||||||
Loading xslF345X03/ownership.xml…